Thomas E. Lad

3.2k total citations
74 papers, 1.9k citations indexed

About

Thomas E. Lad is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Thomas E. Lad has authored 74 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Thomas E. Lad's work include Lung Cancer Treatments and Mutations (16 papers), Bone health and treatments (14 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Thomas E. Lad is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Bone health and treatments (14 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Thomas E. Lad collaborates with scholars based in United States, Canada and Chile. Thomas E. Lad's co-authors include Lynn L. Anderson, Subhash C. Kukreja, Steven Piantadosi, David Cella, Giuseppe Giaccone, Paul S. Thomas, John Ruckdeschel, David Payne, Sofia F. Garcia and Arthur A. Stone and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Thomas E. Lad

69 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas E. Lad United States 22 1.1k 618 291 276 272 74 1.9k
Kirsten A. Nyrop United States 28 1.4k 1.3× 530 0.9× 351 1.2× 136 0.5× 230 0.8× 99 2.9k
James D. Bearden United States 31 1.7k 1.5× 888 1.4× 235 0.8× 252 0.9× 304 1.1× 94 3.1k
Kengo Nagashima Japan 25 715 0.7× 617 1.0× 523 1.8× 237 0.9× 259 1.0× 191 2.0k
Maureen P. Neary United States 25 717 0.7× 538 0.9× 362 1.2× 535 1.9× 263 1.0× 111 2.4k
Irene S. Tekawa United States 23 993 0.9× 635 1.0× 403 1.4× 373 1.4× 152 0.6× 29 2.6k
Tineke J. Smilde Netherlands 25 631 0.6× 524 0.8× 629 2.2× 206 0.7× 319 1.2× 71 2.3k
Simon Allan United Kingdom 19 1.1k 1.0× 521 0.8× 457 1.6× 85 0.3× 177 0.7× 54 2.0k
Ahmet Alacacıoğlu Türkiye 25 948 0.9× 369 0.6× 254 0.9× 199 0.7× 264 1.0× 159 2.0k
Åsa Klint Sweden 26 1.1k 1.0× 464 0.8× 360 1.2× 348 1.3× 183 0.7× 34 2.3k
Mario Di Palma France 28 971 0.9× 1.1k 1.8× 489 1.7× 94 0.3× 265 1.0× 121 2.5k

Countries citing papers authored by Thomas E. Lad

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Lad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Lad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Lad more than expected).

Fields of papers citing papers by Thomas E. Lad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Lad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Lad. The network helps show where Thomas E. Lad may publish in the future.

Co-authorship network of co-authors of Thomas E. Lad

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Lad. A scholar is included among the top collaborators of Thomas E. Lad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Lad. Thomas E. Lad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moreno, Patricia I., Edgar Muñoz, Thomas E. Lad, et al.. (2024). Effects of a culturally tailored patient navigation program on unmet supportive care needs in Hispanic/Latino cancer survivors: A randomized controlled trial. Cancer. 131(1). e35626–e35626. 3 indexed citations
2.
Witt, Thomas R., et al.. (2023). Comparison of gut microbiome composition in colonic biopsies, endoscopically-collected and at-home-collected stool samples. Frontiers in Microbiology. 14. 1148097–1148097. 16 indexed citations
3.
Penedo, Frank J., Amelie G. Ramírez, Manuel S. Ortíz, et al.. (2023). Cardiometabolic comorbidities in Hispanic/Latino cancer survivors: prevalence and impact on health-related quality of life and supportive care needs. Supportive Care in Cancer. 31(12). 711–711. 1 indexed citations
4.
George, Sara M. St., Patricia I. Moreno, Tae Kyoung Lee, et al.. (2022). A latent class analysis of health behavior changes after cancer diagnosis among Hispanic/Latino cancer survivors. Journal of Cancer Survivorship. 18(3). 739–749.
5.
Moreno, Patricia I., Amelie G. Ramírez, Rina S. Fox, et al.. (2018). Unmet supportive care needs in Hispanic/Latino cancer survivors: prevalence and associations with patient-provider communication, satisfaction with cancer care, and symptom burden. Supportive Care in Cancer. 27(4). 1383–1394. 55 indexed citations
6.
7.
Yount, Susan, Nan Rothrock, Michael Bass, et al.. (2013). A Randomized Trial of Weekly Symptom Telemonitoring in Advanced Lung Cancer. Journal of Pain and Symptom Management. 47(6). 973–989. 67 indexed citations
8.
Gupta, Shweta, et al.. (2013). Very High Alpha-Fetoprotein (Afp): a Poor Prognostic Indicator in Hepatocellular Carcinoma in the Modern Era. Annals of Oncology. 24. iv67–iv67. 2 indexed citations
9.
Bhimaraj, Arvind, et al.. (2008). Trastuzumab Mediated Cardiac Dysfunction in the Clinical Setting. Journal of Cardiac Failure. 14(6). S82–S82. 2 indexed citations
10.
Garcia, Sofia F., David Cella, Steven B. Clauser, et al.. (2007). Standardizing Patient-Reported Outcomes Assessment in Cancer Clinical Trials: A Patient-Reported Outcomes Measurement Information System Initiative. Journal of Clinical Oncology. 25(32). 5106–5112. 316 indexed citations
11.
Lad, Thomas E., et al.. (2000). Phase II Trial of Aminocamptothecin (9-AC/DMA) in Patients with Advanced Squamous Cell Head and Neck Cancer. Investigational New Drugs. 18(3). 261–263. 13 indexed citations
12.
Warnecke, Richard B., Timothy P. Johnson, Diane O'Rourke, et al.. (1996). Measuring quality of life in culturally diverse populations.. PubMed. 29–38. 43 indexed citations
13.
Udeani, George, Kamaleshwar P. Singh, Michael Russell Mullane, & Thomas E. Lad. (1996). Cisplatln Nephrotoxicity in a Patient with a Single Kidney. Annals of Pharmacotherapy. 30(7-8). 782–786. 1 indexed citations
14.
Reddy, Sarada P., et al.. (1995). Radiotherapy Alone Compared with Radiotherapy and Chemotherapy in Patients with Squamous Cell Carcinoma of the Esophagus. American Journal of Clinical Oncology. 18(5). 376–381. 5 indexed citations
15.
Locker, Gershon Y., Janardan D. Khandekar, Thomas E. Lad, et al.. (1994). High-dose aminothiadiazole in advanced colorectal cancer. Investigational New Drugs. 12(4). 299–301. 5 indexed citations
16.
Shevrin, Daniel H., Thomas E. Lad, Michael Russell Mullane, et al.. (1994). Phase II trial of 6-thioguanine in advanced renal cell carcinoma. Investigational New Drugs. 12(4). 345–346. 2 indexed citations
17.
Lad, Thomas E., et al.. (1992). Phase II trial of caracemide (NSC 253272) in advanced unresectable non-small cell bronchogenic carcinoma. Investigational New Drugs. 10(1). 27–28. 7 indexed citations
18.
Lad, Thomas E., et al.. (1989). Phase II trial of fludarabine phosphate in advanced renal cell carcinoma: An Illinois Cancer Council study. Investigational New Drugs. 7(2-3). 251–253. 8 indexed citations
19.
Sadeghi, Ahmad, David G. Payne, Larry Rubinstein, & Thomas E. Lad. (1988). Combined modality treatment for resected advanced non-small cell lung cancer: local control and local recurrence. International Journal of Radiation Oncology*Biology*Physics. 15(1). 89–97. 52 indexed citations
20.
Kukreja, Subhash C., et al.. (1988). Hypocalcemia in patients with prostate cancer. Calcified Tissue International. 43(6). 340–345. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kirsten A. Nyrop Breakdown of academic impact, for papers by James D. Bearden Breakdown of academic impact, for papers by Kengo Nagashima Breakdown of academic impact, for papers by Maureen P. Neary Breakdown of academic impact, for papers by Irene S. Tekawa Breakdown of academic impact, for papers by Tineke J. Smilde Breakdown of academic impact, for papers by Simon Allan Breakdown of academic impact, for papers by Ahmet Alacacıoğlu Breakdown of academic impact, for papers by Åsa Klint Breakdown of academic impact, for papers by Mario Di Palma
Rankless by CCL
2026